European Journal of Cancer
Volume 45, Issue 18 , Pages 3166-3171, December 2009

An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence

Clinical and Descriptive Epidemiology Unit, ISPO – Cancer Prevention and Research Institute, via San Salvi 12, 50135 Florence, Italy

Received 20 March 2009; received in revised form 18 May 2009; accepted 12 June 2009. published online 30 October 2009.

Abstract 

Aim

Several studies have tried to quantify overdiagnosis of breast cancer with mammography screening, but estimates vary widely. The aim of this study is to evaluate the degree of overdiagnosis of breast cancer 15 years after the introduction of service screening in Florence (Italy).

Methods

We selected 61,568 women aged 50–69 years at the beginning of service screening (1990) and we used the cancer registry data to follow up them for breast cancer incidence. The measure of overdiagnosis is the ratio of cumulative incidence of breast cancer in the invited group (observed) at least 5 years after the last screening to that expected in the absence of screening.

Results

Under the assumption of a 1.2% annual trend in pre-screening incidence in women aged 60–69 years at the start of service screening, the ratio of observed to expected cumulative cases was 1.01 (95%CI: 0.95–1.07), but assuming no incidence trend, an unlikely scenario, the estimate of overdiagnosis rose to 1.13 (95%CI: 1.07–1.19).

Conclusion

Overdiagnosis of breast cancer in Florentine service screening can be estimated only for women aged 60–69 years at the start of service screening, for it is only for this group that a sufficient follow-up period is available after the last screening. Although the estimate of overdiagnosis is very sensitive to pre-screening trend estimates, our data show that 15 years after the introduction of mammographic service screening the degree of overdiagnosis was nearly zero and more than likely lower than 13% in this age group.

Keywords: Breast cancer, Overdiagnosis, Service screening

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0959-8049(09)00460-2

doi:10.1016/j.ejca.2009.06.014

European Journal of Cancer
Volume 45, Issue 18 , Pages 3166-3171, December 2009